Roche, the Swiss pharmaceutical company at the centre of the row overcancer drugs pricing, played a significant part in the genesis ...
NICE has approved the use of nalmefene to help people who are dependent on alcohol to cut down on the ...
A stakeholder meeting was held on 31 July 2014 to discuss the Pharmaceutical Benefits Scheme (PBS) listing of ivacaftor (Kalydeco) ...
Public consultation on the Authority Required PBS medicines is now open and interested stakeholders can provide comments about any of ...
Data newly released by the Organisation for Economic Cooperation and Development (OECD) reveals that Australia is not matching other industrialised ...
Hospira, Inc., a global leader in biosimilars and the world's leading provider of injectable drugs and infusion technologies, announces the ...
Novartis announced today that Health Canada has approved Cosentyx (secukinumab) for the treatment of moderate to severe plaque psoriasis in adult ...
The April 2015 issue of the New Zealand Pharmaceutical Schedule is out and now in effect. There are no new major ...
Novo Nordisk today announces that the Québec government has approved the inclusion of Victoza (liraglutide), the first once-daily human glucagon-like peptide-1 ...
14 July 2014 - PHARMAC is pleased to announce the decision to award the tender to Norgine for Sole Subsidised Supply ...
Since Andrew Lansley announced in 2010 that the NHS would in future use “value based pricing” in its purchases of pharmaceuticals, civil ...
Genzyme, a Sanofi company, announced today that the Saskatchewan Drug Program has included Aubagio (teriflunomide) 14 mg on the provincial drug ...
The agenda for the 15 April 2015 TC meeting is now available. The Commission will consider the following technologies: ...